The Private Equity Boston Forum is the leading East Coast investor-centric event for LPs investing in private markets.
The forum brings together investors, fund managers, and advisers for a two-day meeting to discuss sectors, due diligence, and private equity investment opportunities in The US and around the world.
The investor-focused event provides a due diligence forum for pension funds, foundations, endowments, funds of funds, family offices, wealth managers, consultants, and sovereign wealth funds interested in direct research on private investment opportunities.
Session topics cover the entire spectrum of private equity investments, from sector-specific sessions to discussions on global buyout opportunities and roundtables of leading global institutional investors discussing their specific investment appetites.
KEYNOTE SPEAKERS
|
Chris Gaffney, Co-Founder and Managing Director, Great Hill Partners Chris Gaffney is Co-Founder and Managing Director of Great Hill Partners, where he is responsible for investment policy, investor relations and the general management of the firm. Chris is also a member of the firm’s executive and investment committees. Throughout the course of his over 37-year career in private equity, Chris has participated in investments covering a range of industries, including software, robotics and AI, information services, e-commerce, consumer and online services, financial technology, digital publishing, among others. Chris has served on over 50 boards from early-stage companies to publicly traded businesses with multiple investments grown from seed stage to unicorn status. |
|
John Maldonado, Managing Partner, Advent International John Maldonado joined Advent in 2006 focusing on buyouts in the healthcare, financial and business services sectors. His previous private equity experience includes positions at both Bain Capital and Parthenon Capital. John began his career as a Consultant with The Par-thenon Group, a leading strategy consulting firm. John earned a BA, summa cum laude, from Dartmouth College and an MBA, with high distinction, as a Baker Scholar from Harvard Business School. During his career, John has worked on 27 investments, 22 during his time at Advent, including Bharat Serums and Vaccines, Cotiviti, Definitive Healthcare, Genoa Healthcare, Iodine Software, Simtra BioPharma Solutions, and Suven Pharmaceuticals. |
PAST SPEAKERS
Sean Ward Senior Managing Director Blue Owl Capital
Bobby Campbell Managing Director—Credit KKR
George Cole Managing Partner The Riverside Company
Ritika Chandra Head of ESG TA Associates
Jason Scoffield Chief Compliance Officer Audax Group
Katie Czerepak Head of Talent, Tech Opportunities, Bain Capital
Carolyn Wintner Managing Director and Head of Capital Markets Charlesbank Capital Partners
Leland Richards Partner, Private Credit Adams Street Partners
Brian Kasser Talent Partner Welsh, Carson, Anderson & Stowe
Jarid Colucci Managing Director & Co-Head BlackRock Secondaries BlackRock
Boriana Karastoyanova Managing Director Neuberger Berman
Sebastien Bilodeau President and Managing Director Cerberus Capital Management
John Knapp Operating Director, Portfolio Talent Berkshire Partners
Ganesh Rao Managing Director Thomas H. Lee Partners
Karen Simeone Managing Director - Credit HarbourVest Partners
Jeffrey Gordon Managing Partner The Riverside Company
Lisa Cohen Founder, Board Chair and Chief Executive Officer Visible National Trust and Visible Foundation
Hillary Flynn Senior Managing Director, Director of ESG Wellington Management
PLATINUM SPONSORS
GOLD SPONSORS
SILVER SPONSORS
REQUEST AGENDA
Please note only corporate email addresses will be accepted.
Why do I need to enter my corporate email address?
By using your corporate email address, we can verify that you are a registered financial professional.
Key Discussion Topics
Panel Discussion: Investing in US Private Equity
With an uncertain overall outlook for pricing and opportunities, how can fund managers remain both informed and flexible about the state of the market? Leading fund managers discuss their investment thesis regarding investment strategies, favorable sectors, exits, and portfolio company management.
Panel Discussion: Investing in Private Equity Healthcare
As investors took to resilient sectors capable of withstanding inflation and market contraction, healthcare has become a more attractive investment. From biopharma to medtech, diagnostics and healthcare IT, which subsectors are offering optimal returns? Experts discuss the most promising and challenging outlooks on healthcare investing.
Panel Discussion: Private Credit—Challenges, Risks, and Opportunities
An allocation to credit can offer higher risk adjusted returns, boost diversification, and provide new income streams. In 2023, we saw a clear shift in the market as a result of the continuous increases in interest rates, which resulted in private credit activity skyrocketing. Join leading fund manager as they discuss lender dynamics, deal terms, market competitive[1]ness and their outlook on the asset class throughout 2024.
Panel Discussion: Middle Market & Growth Investing
In this crowded private market, where high valuations are slowing the investment pace, GPs have been forced to be more creative in finding value. Increasingly, in the middle market more firms are seeking growth equity investment opportunities rather than traditional leveraged buyouts. Hybrid, crossover and growth funds are on the rise. How are investors sourcing deals for non-control investments? What challenges and opportunities lie ahead in the realm of growth investing for managers and institutional investors?
REGISTRATION
INVESTORS: Complimentary Registration for all qualified investors. Email [email protected] for more information on obtaining a complimentary ticket.
MANAGERS & SERVICE PROVIDERS: Rates below reflect the current price for all asset managers and service providers.
VENUE
CONTACT
Copyright © 2024 Markets Group | Terms & Conditions | Privacy Policy
